+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Melanoma Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4719835
  • Report
  • November 2018
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celgene
  • Eli Lilly
  • MORE
The report on the global melanoma drug market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global melanoma drug market to grow with a CAGR of 12.56% over the forecast period from 2018-2024. The study on melanoma drug market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on melanoma drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global melanoma drug market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global melanoma drug market over the period of 2016 to 2024. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Rising Occurences of Malignant Melanoma
  • Growing Awareness about Diagnosis and Cure of Melanoma
  • Increasing UV Exposure
2. Restraints
  • Time-consuming Regulatory Compliance
3. Opportunities
  • Increasing Innovations in Immuno-therapeutics to Enhance Success Rates
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global melanoma drug market is segmented on the basis of type of melanoma, and therapy.

The Global Melanoma Drug Market by Type of Melanoma
  • Superficial Spreading Melanoma
  • Nodular Melanoma
  • Lentigo Maligna Melanoma
  • Acral Lentiginous Melanoma
The Global Melanoma Drug Market by Therapy
  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Company Profiles

The companies covered in the report include:
  • Novartis
  • Amgen
  • Roche
  • Bristol-Myers Squibb
  • Merck & Co.
  • AstraZeneca
  • Eli Lilly
  • Johnson & Johnson
  • Celgene
  • AbbVie
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the melanoma drug market.

2. Complete coverage of all the segments in the melanoma drug market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global melanoma drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celgene
  • Eli Lilly
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Melanoma Drug Market Highlights
2.2. Melanoma Drug Market Projection
2.3. Melanoma Drug Market Regional Highlights

3. Global Melanoma Drug Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type of Melanoma
3.4.2. Growth Matrix Analysis by Therapy
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Melanoma Drug Market

4. Melanoma Drug Market Macro Indicator Analysis

5. Global Melanoma Drug Market by Type of Melanoma
5.1. Superficial Spreading Melanoma
5.2. Nodular Melanoma
5.3. Lentigo Maligna Melanoma
5.4. Acral Lentiginous Melanoma

6. Global Melanoma Drug Market by Therapy
6.1. Immunotherapy
6.2. Chemotherapy
6.3. Targeted Therapy
6.4. Others

7. Global Melanoma Drug Market by Region 2018-2024
7.1. North America
7.1.1. North America Melanoma Drug Market by Type of Melanoma
7.1.2. North America Melanoma Drug Market by Therapy
7.1.3. North America Melanoma Drug Market by Country
7.2. Europe
7.2.1. Europe Melanoma Drug Market by Type of Melanoma
7.2.2. Europe Melanoma Drug Market by Therapy
7.2.3. Europe Melanoma Drug Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Melanoma Drug Market by Type of Melanoma
7.3.2. Asia-Pacific Melanoma Drug Market by Therapy
7.3.3. Asia-Pacific Melanoma Drug Market by Country
7.4. RoW
7.4.1. RoW Melanoma Drug Market by Type of Melanoma
7.4.2. RoW Melanoma Drug Market by Therapy
7.4.3. RoW Melanoma Drug Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Melanoma Drug Market
8.2. Companies Profiles
8.2.1. Novartis
8.2.1.1. Overview
8.2.1.2. Company Snapshot
8.2.1.3. Financial Snapshot
8.2.1.4. Product Portfolio
8.2.1.5. Recent Developments
8.2.2. Amgen
8.2.2.1. Overview
8.2.2.2. Company Snapshot
8.2.2.3. Financial Snapshot
8.2.2.4. Product Portfolio
8.2.2.5. Recent Developments
8.2.3. Roche
8.2.3.1. Overview
8.2.3.2. Company Snapshot
8.2.3.3. Financial Snapshot
8.2.3.4. Product Portfolio
8.2.3.5. Recent Developments
8.2.4. Bristol-Myers Squibb
8.2.4.1. Overview
8.2.4.2. Company Snapshot
8.2.4.3. Financial Snapshot
8.2.4.4. Product Portfolio
8.2.4.5. Recent Developments
8.2.5. Merck & Co.
8.2.5.1. Overview
8.2.5.2. Company Snapshot
8.2.5.3. Financial Snapshot
8.2.5.4. Product Portfolio
8.2.5.5. Recent Developments
8.2.6. AstraZeneca
8.2.6.1. Overview
8.2.6.2. Company Snapshot
8.2.6.3. Financial Snapshot
8.2.6.4. Product Portfolio
8.2.6.5. Recent Developments
8.2.7. Eli Lilly
8.2.7.1. Overview
8.2.7.2. Company Snapshot
8.2.7.3. Financial Snapshot
8.2.7.4. Product Portfolio
8.2.7.5. Recent Developments
8.2.8. Johnson & Johnson
8.2.8.1. Overview
8.2.8.2. Company Snapshot
8.2.8.3. Financial Snapshot
8.2.8.4. Product Portfolio
8.2.8.5. Recent Developments
8.2.9. Celgene
8.2.9.1. Overview
8.2.9.2. Company Snapshot
8.2.9.3. Financial Snapshot
8.2.9.4. Product Portfolio
8.2.9.5. Recent Developments
8.2.10. AbbVie
8.2.10.1. Overview
8.2.10.2. Company Snapshot
8.2.10.3. Financial Snapshot
8.2.10.4. Product Portfolio
8.2.10.5. Recent Developments

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3
  • Novartis
  • Amgen
  • Roche
  • Bristol-Myers Squibb
  • Merck & Co.
  • AstraZeneca
  • Eli Lilly
  • Johnson & Johnson
  • Celgene
  • AbbVie
Note: Product cover images may vary from those shown
Adroll
adroll